Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.450
+0.020 (0.58%)
At close: Jun 12, 2026, 4:00 PM EDT
3.450
0.00 (0.01%)
After-hours: Jun 12, 2026, 7:09 PM EDT
Niagen Bioscience Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Niagen Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $12.6. The average 1-year stock price forecast is 265.22% higher than the current stock price, while the lowest is $10 (+189.86%) and the highest is $18 (+421.74%).
Price Target: $12.6 (+265.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +189.86% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 → $11 | Buy | Reiterates | $12 → $11 | +218.84% | May 11, 2026 |
Unknown Analyst Ladenburg Thalmann & Co. No rating | Ladenburg Thalmann & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +247.83% | May 7, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $13 → $12 | Buy | Reiterates | $13 → $12 | +247.83% | May 7, 2026 |
Financial Forecast
Revenue This Year
142.28M
from 129.42M
Increased by 9.94%
Revenue Next Year
166.92M
from 142.28M
Increased by 17.31%
EPS This Year
0.19
from 0.17
Increased by 13.50%
EPS Next Year
0.29
from 0.19
Increased by 52.63%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 144.6M | ||
| Avg | 142.3M | ||
| Low | 139.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.7% | ||
| Avg | 9.9% | ||
| Low | 7.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.19 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 13.5% | ||
| Low | - |